Long-Term Air Pollution Exposure and Severity of Idiopathic Pulmonary Fibrosis Data from the Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry

被引:0
|
作者
Sack, Coralynn [1 ]
Wojdyla, Daniel M. [2 ]
Macmurdo, Maeve G. [3 ]
Gassett, Amanda [1 ]
Kaufman, Joel D. [1 ]
Raghu, Ganesh [1 ]
Redlich, Carrie A. [4 ]
Li, Peide [5 ]
Olson, Amy L. [5 ]
Leonard, Thomas B. [5 ]
Todd, Jamie L. [2 ,6 ]
Neely, Megan L. [2 ,6 ]
Snyder, Laurie D. [2 ,6 ]
Gulati, Mridu [4 ]
机构
[1] Univ Washington, 303 Roosevelt One Bldg,4225 Roosevelt Way NE, Seattle, WA 98105 USA
[2] Duke Clin Res Inst, Durham, NC USA
[3] Cleveland Clin, Cleveland, OH USA
[4] Yale Sch Med, New Haven, CT USA
[5] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[6] Duke Univ, Med Ctr, Durham, NC USA
关键词
interstitial lung diseases; pulmonary fibrosis; pollution; ACUTE EXACERBATION; ASSOCIATION; DIAGNOSIS; SURVIVAL;
D O I
10.1513/AnnalsATS.202404-382OC
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Rationale: Although exposure to air pollution is a known risk factor for adverse pulmonary outcomes, its impact in individuals with idiopathic pulmonary fibrosis (IPF) is less well understood. Objectives: To investigate the effects of long-term exposure to air pollution on disease severity and progression in patients with IPF and to determine whether genomic factors, such as MUC5B promoter polymorphism or telomere length, modify these associations. Methods: We performed analyses at enrollment and after 1 year of follow-up in the IPF-PRO (Idiopathic Pulmonary Fibrosis Prospective Outcomes) Registry, a prospective observational registry that enrolled individuals with IPF at 46 U.S. sites from June 2014 to October 2018. Five-year average pollution exposures (particulate matter <= 2.5 mu m in aerodynamic diameter [PM2.5], nitrogen dioxide, ozone) before the enrollment date were estimated at participants' residential addresses with validated national spatiotemporal models. Multivariable regression models estimated associations between pollution exposure and physiologic measurements (forced vital capacity [FVC], diffusing capacity of the lung for carbon monoxide, supplemental oxygen use at rest) and quality-of-life measurements (St. George's Respiratory Questionnaire, EuroQoL, Cough and Sputum Assessment Questionnaire) at enrollment. Cox proportional hazards models estimated associations between pollutants and a composite outcome of death, lung transplant, or >10% absolute decline in FVC percent predicted in the year after enrollment. Models were adjusted for individual-level and spatial confounders, including proxies for disease onset. Gene-environment interactions with MUC5B and telomere length were assessed. Results: Of 835 participants, 94% were non-Hispanic White individuals, 76% were male, and the mean (standard deviation) age was 70 (7.7) years. In fully adjusted analyses, higher PM2.5 exposure was associated with worse quality of life per St. George's Respiratory Questionnaire activity score (3.48 [95% confidence interval (CI), 0.64, 6.32] per 2 mu g/m(3) PM2.5) and EuroQoL scores (-0.04 [95% CI, -0.06, -0.01] per 2 mu g/m(3) PM2.5), as well as lower FVC percent predicted and lower diffusing capacity of the lung for carbon monoxide percent predicted at enrollment(.) Each 3 parts per billion difference in O-3 exposure was associated with a 1.57% (95% CI, 0.15, 2.98) higher FVC percent predicted at enrollment, although this effect was attenuated in multipollutant models. There was no association between nitrogen dioxide and enrollment measures or between pollution exposure and 1-year outcomes and no evidence for gene-environment interactions. Conclusions: In the IPF-PRO Registry, long-term exposure to PM2.5 was associated with worse quality of life and lung function at enrollment, but not with short-term disease progression or mortality. There was no evidence of effect modification by interaction of genomic factors with pollution. The reason for the unexpected relationship between O-3 exposure and higher FVC is unclear.
引用
收藏
页码:378 / 386
页数:9
相关论文
共 50 条
  • [1] Long-term Air Pollution Exposure Is Associated With Increased Severity of Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry
    Sack, C.
    Wojdyla, D.
    Macmurdo, M. G.
    Gassett, A.
    Kaufman, J. D.
    Raghu, G.
    Redlich, C. A.
    Li, P.
    Olson, A. L.
    Leonard, T. B.
    Todd, J. L.
    Neely, M. L.
    Snyder, L. D.
    Gulati, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [2] CHARACTERISTICS OF LONG-TERM SURVIVORS WITH IDIOPATHIC PULMONARY FIBROSIS: DATA FROM THE IPF-PRO REGISTRY
    Kim, Hyun
    Bender, Shaun
    Patel, Nina
    Neely, Megan
    Conoscenti, Craig
    Leonard, Thomas
    Palmer, Scott
    CHEST, 2021, 160 (04) : 1251A - 1251A
  • [3] PREDICTING LONG-TERM SURVIVAL IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS: DATA FROM THE IPF-PRO REGISTRY
    Kim, Hyun J.
    Weber, Jeremy
    Neely, Megan L.
    Case, Amy H.
    Jbeli, Aiham
    Li, Peide
    Olson, Amy L.
    Snyder, Laurie D.
    CHEST, 2024, 166 (04) : 3255A - 3256A
  • [4] Predictors of Long-Term Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry
    Kim, Hyun J.
    Weber, Jeremy M.
    Neely, Megan L.
    Case, Amy Hajari
    Jbeli, Aiham H.
    Li, Peide
    Olson, Amy L.
    Snyder, Laurie D.
    IPF PRO Registry investigators, Albert
    LUNG, 2025, 203 (01)
  • [5] Survival in Patients with Idiopathic Pulmonary Fibrosis (IPF): Data from the IPF-PRO Registry
    Palmer, S. M.
    Snyder, L.
    Neely, M. L.
    Yow, E.
    Bender, S.
    Culver, D. A.
    de Andrade, J.
    Gulati, M.
    Kaner, R. J.
    Leonard, T.
    O'Brien, E.
    Pushlar, N.
    Conoscenti, C. S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [6] BASELINE CHARACTERISTICS OF PATIENTS IN THE IDIOPATHIC PULMONARY FIBROSIS PROSPECTIVE OUTCOMES (IPF-PRO) REGISTRY
    Culver, Daniel
    Yow, Eric
    Neely, Megan
    Bender, Shaun
    Dilling, Daniel
    Oldham, Justin
    Palmer, Scott
    Conoscenti, Craig
    CHEST, 2020, 158 (04) : 1040A - 1041A
  • [7] Rationale for and design of the Idiopathic Pulmonary Fibrosis-PRospective Outcomes (IPF-PRO) registry
    O'Brien, Emily C.
    Durheim, Michael T.
    Gamerman, Victoria
    Garfinkel, Sandy
    Anstrom, Kevin J.
    Palmer, Scott M.
    Conoscenti, Craig S.
    BMJ OPEN RESPIRATORY RESEARCH, 2016, 3 (01):
  • [8] HOSPITALIZATIONS AND OUTCOMES IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): INSIGHTS FROM THE IPF-PRO REGISTRY
    Kim, Hyun
    Neely, Megan
    Janssen, Katherine
    Adegunsoye, Ayodeji
    Strek, Mary
    Yow, Eric
    Conoscenti, Craig
    Leonard, Thomas
    Snyder, Laurie
    CHEST, 2020, 158 (04) : 1062A - 1063A
  • [9] Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
    Snyder, Laurie D.
    Mosher, Christopher
    Holtze, Colin H.
    Lancaster, Lisa H.
    Flaherty, Kevin R.
    Noth, Imre
    Neely, Megan L.
    Hellkamp, Anne S.
    Bender, Shaun
    Conoscenti, Craig S.
    de Andrade, Joao A.
    Whelan, Timothy P. M.
    BMJ OPEN RESPIRATORY RESEARCH, 2020, 7 (01)
  • [10] Time to Diagnosis of Idiopathic Pulmonary Fibrosis in the IPF-PRO Registry
    Snyder, L. D.
    Mosher, C.
    Holtze, C. H.
    Lancaster, L. H.
    Flaherty, K. R.
    Noth, I.
    Neely, M. L.
    Hellkamp, A. S.
    Bender, S.
    Conoscenti, C. S.
    De Andrade, J. A.
    Whelan, T. P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201